Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

Completed

Conditions studied: Liver Tumor

In brief

The purpose of this study is to prospectively compare the physiologic response of patients who receive either intravenous gadoxetic acid (Eovist) or intravenous gadobenate dimeglumine (MultiHance).

Key facts

Study ID

NCT02226666

Run by

University of Michigan

People needed

107

Starts

2013-08-01

Expected to finish

2015-12-01

Last updated by the study team

2017-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years old and older
• Patients scheduled for MRI examination at the University of Michigan hospital
• Patients receiving either MultiHance or Eovist contrast agents during their clinical MRI examination

You may not qualify if…

• Patients under 18 years of age
• Patients who will not receive MultiHance or Eovist as part of their clinical MRI examination

Where it is running

• University of Michigan Hospital — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.